William D. Humphries - 14 Sep 2021 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc

Role
Director
Signature
/s/ John P. Sharp, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
14 Sep 2021
Net transactions value
$0
Form type
4
Filing time
15 Sep 2021, 08:15:34 UTC
Previous filing
23 Aug 2021
Next filing
11 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHASQ Non-employee Director Stock Option (right to buy) Award $0 +28,000 $0.000000 28,000 14 Sep 2021 Common Stock 28,000 $2.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest in equal monthly installments over 36 months from September 14, 2021, subject to the reporting person's continued service through each such date.